Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses

Siddhartha Mahanty, Karen Hutchinson, Sudhanshu Agarwal, Michael Mcrae, Pierre E. Rollin and Bali Pulendran
J Immunol March 15, 2003, 170 (6) 2797-2801; DOI: https://doi.org/10.4049/jimmunol.170.6.2797
Siddhartha Mahanty
*Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Hutchinson
*Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudhanshu Agarwal
†Emory Vaccine Research Center and Department of Pathology, Emory University, Atlanta, GA 30329
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Mcrae
†Emory Vaccine Research Center and Department of Pathology, Emory University, Atlanta, GA 30329
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre E. Rollin
*Special Pathogens Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bali Pulendran
†Emory Vaccine Research Center and Department of Pathology, Emory University, Atlanta, GA 30329
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Infection of MDDC by Ebola and Lassa viruses. A, Survival of MDDC following Ebola and Lassa virus infection. MDDC (1 × 106 cells) were infected with Ebola or Lassa virus and cultured at 37°C for 6 days. Surviving cells were enumerated by trypan blue exclusion and survival (%) were calculated on days 2, 4, and 6. Inactivated Ebola and Lassa virus, at the same moi, were used as controls. Bars represent the means of two replicate wells, and the error bars represent the SEM. Med, Uninfected cells. B, Immunofluorescence assay showing infection of MDDC by Ebola and Lassa viruses. MDDC cultured with live or inactivated Ebola or Lassa virus for 48 h were fixed with cold acetone, and viral Ags were detected using a pool of monoclonal (for Ebola) or polyclonal Abs (Lassa) (see Materials and Methods) followed by FITC-labeled anti-IgG conjugates. The left upper and lower panels are infected MDDC incubated with normal mouse (for Ebola) or rabbit (Lassa) sera as negative controls. C, Viral replication in MDDC. Live virus was quantified in 48-h cell supernatants of MDDC infected with Ebola or Lassa virus (or inactivated virus as controls) by focus-forming assays. The bar labeled “Start” is the titer of the live virus used to infect each well at the beginning of culture. Bars represent the means of three wells and the error bars represent the SEM.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Secretion of inflammatory and anti-inflammatory mediators and activation of MDDC in response to Ebola and Lassa viruses. A, Cytokine and chemokine secretion by MDDC (0.5 × 106 cells) cultured for 48 h with live or inactivated Ebola or Lassa viruses, or LPS (1 μg/ml). B, Expression of the costimulatory molecules CD86, CD80, and CD40 on MDDC following Ebola and Lassa virus infection. MFI, Mean fluorescence index.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Impaired function of DC infected with Ebola or Lassa virus. DC were infected with Ebola or Lassa, washed, and then cultured with naive, allogeneic CD4+ T cells for 5 days. Uptake of [3H]thymidine is shown in the graph as cpm on the y-axis, and MDDC pretreatment condition is shown on the x-axis. Bars and error bars represent the means of quadruplicate cultures from each of four donors and the SEM. TC, T cells alone; Med, medium.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 170 (6)
The Journal of Immunology
Vol. 170, Issue 6
15 Mar 2003
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
Siddhartha Mahanty, Karen Hutchinson, Sudhanshu Agarwal, Michael Mcrae, Pierre E. Rollin, Bali Pulendran
The Journal of Immunology March 15, 2003, 170 (6) 2797-2801; DOI: 10.4049/jimmunol.170.6.2797

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
Siddhartha Mahanty, Karen Hutchinson, Sudhanshu Agarwal, Michael Mcrae, Pierre E. Rollin, Bali Pulendran
The Journal of Immunology March 15, 2003, 170 (6) 2797-2801; DOI: 10.4049/jimmunol.170.6.2797
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease
  • Cutting Edge: EPHB2 Is a Coreceptor for Fungal Recognition and Phosphorylation of Syk in the Dectin-1 Signaling Pathway
  • Cutting Edge: Hypoxia-Induced Ubc9 Promoter Hypermethylation Regulates IL-17 Expression in Ulcerative Colitis
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606